Pharma Department mulls ban on sale of baby food items at pharmacies

n the wake of Maggi controversy, Department of Pharmaceuticals is mulling to bring a proposal to ban sale of baby food products and other supplements at pharmacies.  The department said only pharmaceutical items like medicines and syrups must be allowed for sale in such shops.  “People purchase baby food products and supplements from chemist shops… Read More Pharma Department mulls ban on sale of baby food items at pharmacies

Pharma industry grappling with pricing, regulatory issues: Survey

Noting a regulatory environment which is more “enabling than restrictive” is required for innovation, a position paper prepared by Pricewaterhouse coopers released at the summit organised by the USA-India Chamber of Commerce (USAIC) said.  ADVERTISING “The Indian government should explore programs and incentives for encouraging non-traditional organisations to partner with it, academia and pharmaceutical companies… Read More Pharma industry grappling with pricing, regulatory issues: Survey

Internal whistleblowers ensure Pharma companies stick to guidelines and rules

The precedent set by former Ranbaxy employee Dinesh Thakur, who blew the lid over the company’s malpractices, has encouraged employees of pharmaceutical firms who have become crusaders of upholding quality and compliance of their respective companies. Research reports released by the forensic divisions of consultancy firm Deloitte and EY reveal a growing trend of whistleblowing… Read More Internal whistleblowers ensure Pharma companies stick to guidelines and rules

The Drug Development Process Explained in Detail and How It Impacts Your Investments

Bringing a drug to market is truly an arduous process that most consumers take for granted. According to Medscape, only one in every 5,000 to 10,000 drugs that enter preclinical studies will ever make it onto pharmacy shelves. In context, CNN reports that the odds of having 12 children in a row that are boys… Read More The Drug Development Process Explained in Detail and How It Impacts Your Investments

Study Shows Genetic Support for Drug Targets Could Double Clinical Development Success Rate

NEW YORK (GenomeWeb) – Pursuing drug targets that have supporting genetic evidence could double the clinical development success rate, according to researchers led by GlaxoSmithKline’s Philippe Sanseau. More than half of clinical trials fail because the drugs are not effective, and drawing on genes that have been linked to disease could help inform the drug… Read More Study Shows Genetic Support for Drug Targets Could Double Clinical Development Success Rate

New technology can detect illegal drugs from a single fingerprint

An innovative technology pioneered by Sheffield Hallam University academics can detect the presence of a range of illegal and designer drugs from a single fingerprint, which could be a valuable new tool in bringing drug dealers and other criminals to justice. The journal ‘Scientific Reports’ has published a new paper confirming the technology, known as… Read More New technology can detect illegal drugs from a single fingerprint